CF
MDT icon

Corebridge Financial’s Medtronic MDT Stock Holding History

Corebridge Financial’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-285,995
Closed -$25.7M – 1632
2025
Q1 		$25.7M Sell
285,995
-8,757
-3% -$784K 0.15% 107
2024
Q4 		$23.5M Sell
294,752
-14,153
-5% -$1.23M 0.13% 117
2024
Q3 		$27.8M Sell
308,905
-20,157
-6% -$1.7M 0.15% 98
2024
Q2 		$25.9M Buy
+329,062
New +$27M 0.14% 99

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corebridge Financial's MDT Position: Q2 2025 in Review

Corebridge Financial sold out of Medtronic (MDT) in Q2 2025, closing a stake of 285,995 shares — an estimated $25.7M sold.

Corebridge Financial first reported a position in MDT in Q2 2024 and held it in 4 quarters. The position peaked at $27.8M in Q3 2024. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Corebridge Financial reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 285,995 Medtronic shares in Q2 2025, an estimated $25.7M.
  • Corebridge Financial first reported a position in Medtronic in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Medtronic position peaked at $27.8M in Q3 2024.
  • 2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.